Interv Akut Kardiol. 2018;17(3):148-151 | DOI: 10.36290/kar.2018.051

The use of autologous bone marrow stem cells in the treatment of heart failure

Leoš Pleva1, Pavel Kukla1, Kateřina Vítková2, Václav Procházka3
1 Kardiovaskulární oddělení, Fakultní nemocnice Ostrava
2 Oddělení pro vědu a výzkum, Fakultní nemocnice Ostrava
3 Radiodiagnostický ústav, Fakultní nemocnice Ostrava

Heart failure is a major chronic illness, resulting in high morbidity and mortality. The most frequent cause of heart failure withreduced ejection fraction is coronary artery disease. Although revascularisation of ischaemic myocardium leads to improvementsin contractility of viable myocardium and systolic function, it can not restore the viability of an already necrotic tissue. In our review,we focus on the use of autologous bone marrow stem cells in the treatment of patients with heart failure due to ischaemicmyocardial injury.

Keywords: autologous bone marrow cells, heart failure, myocardial regeneration

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pleva L, Kukla P, Vítková K, Procházka V. The use of autologous bone marrow stem cells in the treatment of heart failure. Interv Akut Kardiol. 2018;17(3):148-151. doi: 10.36290/kar.2018.051.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 2016; 37(27): 2129-2200. Go to original source... Go to PubMed...
    2. Lerman DA, Alotti N, Ume KL, Péault B. Cardiac repair and regeneration: the value of cell therapies. European Cardiology Review 2016; 11(1): 43-48. Go to original source... Go to PubMed...
    3. Katarzyna R. Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical trials. Curr Cardiol Rev. 2017; 13(3): 223-231. Go to original source...
    4. Takashima S, Tempel D, Duckers HJ. Current outlook of cardiac stem cell therapy towards a clinical application. Heart 2013; 0: 1-13. Go to original source...
    5. Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. BioMed Research International. 2013; Article ID 547902: 1-15. http://dx.doi.org/10.1155/2013/547902 Go to original source...
    6. Wu KH, Hanb ZC, Moa XM, et al. Cell delivery in cardiac regenerative therapy. Ageing Research Reviews 2012; 11: 32-40. Go to original source... Go to PubMed...
    7. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart from the methodological origin to clinical practice. JACC 2011; 58(11): 1095-104. Go to original source...
    8. Gyöngyösi M, Giurgea GA, Syeda B, et al. Long-Term Outcome of combined (percutaneous intramyocardial and intracoronary) application of autologous bone marrow mononuclear cells post myocardial infarction: The 5-Year MYSTAR Study. PLoS One. 2016; 11(10): e0164908. Go to original source... Go to PubMed...
    9. Wu K, Mo X, Lu S, Han Z. Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerative therapy. Clin Transplant 2011: 25: 830-833. Go to original source...
    10. Suzuki K, Murtuza B, Fukushima S, et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation 2004; 110(11): II225-230. Go to original source...
    11. Zhou R, Acton PD, Victor A. Ferrari VA. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 2006; 48: 2094-2106. Go to original source...
    12. van der Spoel TIG, Lorkeers SJ, Agostoni P, et al. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.. Cardiovascular Research. 2011; 91: 649-658. Go to original source...
    13. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters a systematic review and meta-analysis. Circulation 2012; 126: 551-568. Go to original source...
    14. Delewi R, Andriessen A, Tijssen JGP, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013; 99: 225-232. Go to original source...
    15. Pudil R, Vojáček J, Filip S, et al. Transplantation of bone marrow derived progenitor cells in acute myocardial infarction. The first results. Acta Medica (Hradec Králové) 2005; 48(3-4): 153-155. Go to original source... Go to PubMed...
    16. Pudil R, Vojacek J, Filip S, et al. Transplantation of bone marrow derived progenitors in acute myocardial infarction. Two-year follow-up. [abstract] Journal of Molecular and Cellular Cardiology 2007; 42: S88-S101. Go to original source...
    17. Pěnička M, Widimský P, Kobylka P, et al. Transplantace autologních kmenových buněk kostní dřeně po akutním infarktu myokardu, způsobeném uzávěrem kmene levé věnčité tepny. Cor Vasa 2003; 45(9): 465-468.
    18. Penicka M, Horak J, Kobylka P, et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction a prematurely terminated randomized study. JACC 2007; 49(24). Go to original source...
    19. Meluzín J, Mayer J, Groch L, et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006; 152: 975. e9-975.e15. Go to original source...
    20. Meluzín J, Janoušek S, Mayer J, et al. Three-, six-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology 2008; 128: 185-192. Go to original source...
    21. Meluzín J, Janoušek S, Mayer J, et al. Autologous transplantation of mononuclear bone marrow cells in patients with chronic myocardial infarction. Cor Vasa 2007; 49: 46-54. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.